Sherman M - Search Results

1

A multi-analyte cell-free DNA-based blood test for early detection of hepatocellular carcinoma.

Lin N, Lin Y, Xu J, Liu D, Li D, Meng H, Gallant MA, Kubota N, Roy D, Li JS, Gorospe EC, Sherman M, Gish RG, Abou-Alfa GK, Nguyen MH, Taggart DJ, Van Etten RA, Hoshida Y, Li W. Lin N, et al. Among authors: sherman m. Hepatol Commun. 2022 Jul;6(7):1753-1763. doi: 10.1002/hep4.1918. Epub 2022 Mar 3. Hepatol Commun. 2022. PMID: 35244350 Free PMC article.

2

The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop.

Block TM, Marrero J, Gish RG, Sherman M, London WT, Srivastava S, Wagner PD. Block TM, et al. Among authors: sherman m. Cancer Biomark. 2008;4(1):19-33. doi: 10.3233/cbm-2008-4103. Cancer Biomark. 2008. PMID: 18334731 Review.

3

Hepatocellular Carcinoma: Pay Now or Pay More Later.

Sherman M. Sherman M. Ann Hepatol. 2017 Jul-Aug;16(4):478-479. doi: 10.5604/01.3001.0010.0269. Ann Hepatol. 2017. PMID: 28612752 Free article. No abstract available.

4

International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma.

Singal AG, Hoshida Y, Pinato DJ, Marrero J, Nault JC, Paradis V, Tayob N, Sherman M, Lim YS, Feng Z, Lok AS, Rinaudo JA, Srivastava S, Llovet JM, Villanueva A. Singal AG, et al. Among authors: sherman m. Gastroenterology. 2021 Jun;160(7):2572-2584. doi: 10.1053/j.gastro.2021.01.233. Epub 2021 Mar 9. Gastroenterology. 2021. PMID: 33705745 Free PMC article. No abstract available.

5

Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3 cm in potentially transplantable patients.

Doyle A, Gorgen A, Muaddi H, Aravinthan AD, Issachar A, Mironov O, Zhang W, Kachura J, Beecroft R, Cleary SP, Ghanekar A, Greig PD, McGilvray ID, Selzner M, Cattral MS, Grant DR, Lilly LB, Selzner N, Renner EL, Sherman M, Sapisochin G. Doyle A, et al. Among authors: sherman m. J Hepatol. 2019 May;70(5):866-873. doi: 10.1016/j.jhep.2018.12.027. Epub 2019 Jan 5. J Hepatol. 2019. PMID: 30615906

6

Screening for hepatocellular carcinoma in chronic carriers of hepatitis B virus: incidence and prevalence of hepatocellular carcinoma in a North American urban population.

Sherman M, Peltekian KM, Lee C. Sherman M, et al. Hepatology. 1995 Aug;22(2):432-8. Hepatology. 1995. PMID: 7543434 Clinical Trial.

7

Optimization of imaging diagnosis of 1-2 cm hepatocellular carcinoma: an analysis of diagnostic performance and resource utilization.

Khalili K, Kim TK, Jang HJ, Haider MA, Khan L, Guindi M, Sherman M. Khalili K, et al. Among authors: sherman m. J Hepatol. 2011 Apr;54(4):723-8. doi: 10.1016/j.jhep.2010.07.025. Epub 2010 Sep 22. J Hepatol. 2011. PMID: 21156219 Clinical Trial.

8

Risk scores for hepatocellular carcinoma in chronic hepatitis B.

Sherman M, Kim RW, Dziura J. Sherman M, et al. Hepatology. 2015 Jun;61(6):1784-6. doi: 10.1002/hep.27765. Epub 2015 Mar 25. Hepatology. 2015. PMID: 25728409 No abstract available.

9

Capitalising on improved rates of diagnosis of early hepatocellular carcinoma.

Rowe IA, Sherman M. Rowe IA, et al. Among authors: sherman m. J Hepatol. 2016 Feb;64(2):260-261. doi: 10.1016/j.jhep.2015.10.027. Epub 2015 Nov 6. J Hepatol. 2016. PMID: 26551515 No abstract available.

10

Health care costs associated with hepatocellular carcinoma: a population-based study.

Thein HH, Isaranuwatchai W, Campitelli MA, Feld JJ, Yoshida E, Sherman M, Hoch JS, Peacock S, Krahn MD, Earle CC. Thein HH, et al. Among authors: sherman m. Hepatology. 2013 Oct;58(4):1375-84. doi: 10.1002/hep.26231. Epub 2013 Mar 15. Hepatology. 2013. PMID: 23300063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,529 results

Search Page

Filters